SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (1283)1/8/1999 1:03:00 PM
From: Anthony Wong  Respond to of 1722
 
Warner-Lambert Reiterated 'Buy' at PaineWebber

Bloomberg News
January 8, 1999, 7:38 a.m. ET

Princeton, New Jersey, Jan. 8 (Bloomberg Data) -- Warner-Lambert Co.
(WLA US) was reiterated ''buy'' by analyst Jeffrey Chaffkin at PaineWebber Inc.
The 12-month target price is $93.00 per share.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652



To: Anthony Wong who wrote (1283)1/8/1999 1:05:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 1722
 
Immunex Corp. Cut to 'Outperform' at Salomon Smith Barney

Bloomberg News
January 8, 1999, 8:37 a.m. ET

Princeton, New Jersey, Jan. 8 (Bloomberg Data) -- Immunex Corp. (IMNX US)
was downgraded to ''outperform'' from ''buy'' by analyst Meirav Chovav at
Salomon Smith Barney.

-- Sybil Carlson in Princeton, New Jersey, (609)279-3615